Page 171 - 16Neonatal Jaundice_compressed
P. 171

Neonatal jaundice





                         the best interests of the child paramount. Local procedures should be in place to support
                         communication with parents in this situation.
                         The evidence for effectiveness of clofibrate in neonatal jaundice is strong but is confined to one
                         population. The GDG notes that studies of clofibrate in adults reported significant adverse effects.
                                                                                                         227
                         While these findings cannot be directly extrapolated to neonates, this concern, together with the
                         paucity of data, led the GDG to conclude that clofibrate cannot currently be recommended for use
                         in neonatal jaundice. However, the GDG considered that further investigations in UK populations
                         was required and made a research recommendation on this topic.
                         No other interventions are recommended for the treatment of hyperbilirubinemia.

                          Recommendations – 7.4 Other treatments
                          Use intravenous immunoglobulin (IVIG) (500 mg/kg over  4 hours) as an adjunct to
                          continuous multiple phototherapy in cases of Rhesus haemolytic disease or ABO haemolytic
                          disease when the serum bilirubin continues to rise by more than 8.5 micromol/litre per hour.
                          Do not use any of the following to treat hyperbilirubinaemia:
                          •   agar
                          •   albumin
                          •   barbiturates
                          •   charcoal
                          •   cholestyramine
                          •   clofibrate
                          •   D-penicillamine
                          •   glycerin
                          •   manna
                          •   metalloporphyrins
                          •   riboflavin
                          •   traditional Chinese medicine
                          •   acupuncture
                          •   homeopathy.


              7.5        Satisfaction with treatment

                         Description of included studies

                         No studies were identified.

                         Review findings

                         No studies were identified.
                         Evidence summary

                         No evidence has been identified.



















              140
   166   167   168   169   170   171   172   173   174   175   176